BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32703344)

  • 21. Deletions and amplifications of the IGH variable and constant regions:a novel prognostic parameter in patients with multiple myeloma.
    Rabani H; Ziv M; Lavi N; Aviv A; Suriu C; Shalata A; Haddid Y; Tadmor T
    Leuk Res; 2020 Dec; 99():106476. PubMed ID: 33171301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics of patients with multiple myeloma harboring 6q deletion].
    Chen L; Sun CY; An BW; Yu JM; Zhao F; Zhang C; Hu Y
    Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):642-645. PubMed ID: 34547869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].
    Qiu Q; Zhu P; Wang MJ; Lu XZ; Dong YJ; Sun YH; Wang LH; Zhang Y; Bu DF; Wang WS; Liang ZY; Liu W; Qiu ZX; Ou JP; Cen XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1071-8. PubMed ID: 27531777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The significances of 13q14 deletion for development and prognosis of multiple myeloma].
    Li Q; An G; Li CW; Xu Y; Deng SH; Liu XP; Qi JY; Wang YF; Zou DH; Zhao YZ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):217-20. PubMed ID: 21569701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.
    Boyd KD; Ross FM; Walker BA; Wardell CP; Tapper WJ; Chiecchio L; Dagrada G; Konn ZJ; Gregory WM; Jackson GH; Child JA; Davies FE; Morgan GJ;
    Clin Cancer Res; 2011 Dec; 17(24):7776-84. PubMed ID: 21994415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients.
    Geng C; Yang G; Wang H; Wu Y; Leng Y; Zhou H; Zhang Z; Jian Y; Chen W
    Leuk Lymphoma; 2021 Apr; 62(4):883-890. PubMed ID: 33275060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Prognostic Value of Del(1p32) in Patients with Newly Diagnosed Multiple Myeloma].
    Guo R; Shen XX; Xia Y; Jin YY; Li JY; Chen LJ; Qiu HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):768-773. PubMed ID: 38926965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical characteristics and prognosis of newly diagnosed multiple myeloma patients with FGFR3 gene mutations].
    Shen N; Zhang J; Xia Y; Shen XX; Wang J; Jin YY; Zhang R; Li JY; Chen LJ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):989-994. PubMed ID: 38503521
    [No Abstract]   [Full Text] [Related]  

  • 29. Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients.
    Geng C; Yang G; Zhou H; Wang H; Li Y; Leng Y; Zhang Z; Jian Y; Chen W
    Clin Exp Med; 2023 Oct; 23(6):2593-2600. PubMed ID: 36703087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Prognosis of MAF Deletion in Chinese Patients With Multiple Myeloma.
    Wang Y; Li Q; Xing S; Zhang H; Li D
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e545-e550. PubMed ID: 31262667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chromosome 13q deletion detected by interphase FISH in multiple myeloma: a study of 100 cases in China].
    Li Q; Lu Y; Wang YF; Liu XP; Qi JY; Zou DH; Zhao YZ; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1979-82. PubMed ID: 19950573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma.
    Merz M; Hielscher T; Seckinger A; Hose D; Mai EK; Raab MS; Goldschmidt H; Jauch A; Hillengass J
    Am J Hematol; 2016 Nov; 91(11):E473-E477. PubMed ID: 27508939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of CD56 antigen in newly diagnosed multiple myeloma: A real-world retrospective study.
    Li L; Li X; Shang A; Zhao Y; Jin L; Zhao M; Shen W
    Medicine (Baltimore); 2022 Oct; 101(40):e30988. PubMed ID: 36221376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.
    Grzasko N; Hajek R; Hus M; Chocholska S; Morawska M; Giannopoulos K; Czarnocki K; Druzd-Sitek A; Pienkowska-Grela B; Rygier J; Usnarska-Zubkiewicz L; Dytfeld D; Kubicki T; Jurczyszyn A; Korpysz M; Dmoszynska A
    Leuk Lymphoma; 2017 Sep; 58(9):1-15. PubMed ID: 28092996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent era.
    Geng C; Yang G; Zhou H; Wang H; Li Y; Leng Y; Zhang Z; Jian Y; Chen W
    Hematology; 2023 Dec; 28(1):2161222. PubMed ID: 36607148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China.
    Chen Q; Han X; Zheng G; Yang Y; Li Y; Zhang E; Yang L; Dong M; He D; He J; Cai Z
    Front Oncol; 2022; 12():1084683. PubMed ID: 36605445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment options and prognosis in newly diagnosed multiple myeloma patients].
    Wang L; Tang W; Wang Y; Xu L; Zhao WL; Wu W; Chen YB; Shen ZX; Hu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):308-12. PubMed ID: 21729598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of CD200 expression in newly diagnosed multiple myeloma patients and dynamic changing during treatment.
    Shi Q; Wu C; Han W; Zhao S; Wu Y; Jin Y; Qu X; Li J; Zhang R; Chen L
    Leuk Lymphoma; 2021 Mar; 62(3):709-715. PubMed ID: 33108911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients.
    Jian Y; Chen X; Zhou H; Zhu W; Liu N; Geng C; Chen W
    Medicine (Baltimore); 2016 May; 95(19):e3521. PubMed ID: 27175647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
    Grzasko N; Hus M; Pluta A; Jurczyszyn A; Walter-Croneck A; Morawska M; Chocholska S; Hajek R; Dmoszynska A
    Hematol Oncol; 2013 Mar; 31(1):41-8. PubMed ID: 22674819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.